Qiagen Genomics - WA Snohomish, Bothell 98021

Qiagen Genomics entered the industry of Commercial Biotechnical Research in 1999 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 5416900, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Matin Colpan by calling (425) 398-3100 during business hours. You can also write to the business’ Single Location at 1725 220th St Se, Bothell, Washington WA 98021. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Qiagen Genomics
Representative: Matin Colpan
Place of Business: 1725 220th St Se, Bothell, WA 98021
Contact Number: (425) 398-3100
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 5416900
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1999
Income/Year: $1.000.000 to $2.499.999
Laborers: 1 to 4
Share This Company:

Qiagen Genomics is a company operating from Snohomish, Washington providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 1999 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 5416900 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Qiagen Genomics has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Matin Colpan at (425) 398-3100 for related queries, or to locate its Single Location using the coordinates 47.798679,-122.208188.

The Single Location can also be found at the street address 1725 220th St Se in Bothell, Washington 98021 and can be engaged online through the company website at , the company Twitter , and Facebook page .